Primary squamous cell carcinoma arising from palpebral conjunctiva: A rare presentation

Pai, H Vijaya; Handa, Divya; Priya, J Padma

doi:10.4103/ijo.ijo_754_17

Indian J Ophthalmol

2018

DOI: 10.4103/ijo.ijo_754_17

|View full text |Cite

Primary squamous cell carcinoma arising from palpebral conjunctiva: A rare presentation

H Vijaya Pai

Divya Handa

J Padma Priya

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

FIVE YEARS FOLLOW-UP OF CONJUNCTIVAL SQUAMOUS CELL CARCINOMA TREATED WITH ADJUNCTIVE INTERFERON ALPHA-2b

Er,

Ergün,

Koç

et al. 2024

tmsj

View full text Add to dashboard Cite

Conjunctival squamous cell carcinoma mostly arises from the limbal stem cells of the eye. Some of the risk factors for conjunctival squamous cell carcinoma are male gender, advanced age, ultraviolet radiation, and human papillomavirus. Squamous cell carcinoma can manifest with vision loss, ocular redness, mass-feeling, and pain. We aim to present a case of conjunctival squamous cell carcinoma successfully treated with surgical excision, cryotherapy, keratectomy, partial scleral excision, and topical interferon alpha-2b. An 81-year-old male patient presented to the Trakya University Department of Ophthalmology complaining of redness and pain in his left eye. Our patient was diagnosed with squamous cell carcinoma when the pathological examination and clinical picture were reviewed together. The lesion was completely excised with the no-touch technique, and no complications were observed. Pathology specimen showed tumor-free surgical margins. Even though the surgical margins were tumor-free, due to clinical suspicion for recurrence the patient was prescribed topical interferon alpha-2b drops post-operatively and had no recurrence in 5 years of follow-up. In conclusion, although the gold standard treatment in ocular squamous cell neoplasia is still surgical excision with cryogenic therapy, topical chemotherapeutic agents can reveal a good response in the treatment of conjunctival squamous cell carcinoma.

show abstract

FIVE YEARS FOLLOW-UP OF CONJUNCTIVAL SQUAMOUS CELL CARCINOMA TREATED WITH ADJUNCTIVE INTERFERON ALPHA-2b

Er,

Ergün,

Koç

et al. 2024

tmsj

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Primary squamous cell carcinoma arising from palpebral conjunctiva: A rare presentation

Cited by 1 publication

References 9 publications

FIVE YEARS FOLLOW-UP OF CONJUNCTIVAL SQUAMOUS CELL CARCINOMA TREATED WITH ADJUNCTIVE INTERFERON ALPHA-2b

FIVE YEARS FOLLOW-UP OF CONJUNCTIVAL SQUAMOUS CELL CARCINOMA TREATED WITH ADJUNCTIVE INTERFERON ALPHA-2b

Contact Info

Product

Resources

About